Author(s):
P. Devi Guna Sireesha, Shaik Sameer, Shaik Shabreen Begum, Khadar Basha Showkath Basha, Shaik Mubina Begum
Email(s):
devivenkatarao@gmail.com
DOI:
10.52711/2321-5836.2025.00009
Address:
P. Devi Guna Sireesha1*, Shaik Sameer2, Shaik Shabreen Begum2, Khadar Basha Showkath Basha2, Shaik Mubina Begum2
1Assistant Professor, Department of Pharmacology, Nimra College of Pharmacy, Nimra Nagar, Jupudi, Ibrahimpatnam, Vjiayawada, Andhra Pradesh - 521456, India.
2UG Student, Department of Pharmacy, Nimra College of Pharmacy, Nimra Nagar, Jupudi, Ibrahimpatnam, Vijayawada, Andhra Pradesh, India, 521456.
*Corresponding Author
Published In:
Volume - 17,
Issue - 1,
Year - 2025
ABSTRACT:
Monkeypox is an emerging viral zoonotic disease caused by the monkeypox virus, which is particularly significant as it is endemic to Central and Western Africa. This disease is rare and manifests with a rash resembling that of smallpox. However, its transmission between individuals beyond close contact is limited, and the case fatality rates for monkeypox are notably lower than those associated with smallpox. In light of smallpox's eradication, it is essential to accurately diagnose monkeypox symptoms in endemic regions. The monkeypox virus was first identified in laboratory settings in 1958, with the initial human case documented in Africa in 1970. A notable outbreak occurred in 1997, affecting 88 individuals and resulting in three fatalities, all among children and infants under three years old. The clinical presentation of monkeypox resembles that of ordinary smallpox, featuring flu-like symptoms, fever, malaise, back pain, headache and distinctive rashes. Human transmission primarily occurs through direct contact with infected animals or by consuming undercooked animal meat. Infection can also result from contact with mucosal lesions on these animals. Accurate laboratory diagnosis is crucial, as monkeypox can easily be mistaken for other pox-like illnesses. Currently, there are no approved treatments specifically for monkeypox; however, the smallpox vaccine can offer protection against the virus. The cessation of routine smallpox vaccinations in the 1980s has increased the vulnerability of the human population to monkeypox infections. Effective prevention strategies focus on minimizing contact with infected patients or animals and reducing respiratory exposure to those infected.
Cite this article:
P. Devi Guna Sireesha, Shaik Sameer, Shaik Shabreen Begum, Khadar Basha Showkath Basha, Shaik Mubina Begum. Pharmacological Review on Orthopoxvirus. Research Journal of Pharmacology and Pharmacodynamics. 2025; 17(1):52-8. doi: 10.52711/2321-5836.2025.00009
Cite(Electronic):
P. Devi Guna Sireesha, Shaik Sameer, Shaik Shabreen Begum, Khadar Basha Showkath Basha, Shaik Mubina Begum. Pharmacological Review on Orthopoxvirus. Research Journal of Pharmacology and Pharmacodynamics. 2025; 17(1):52-8. doi: 10.52711/2321-5836.2025.00009 Available on: https://rjppd.org/AbstractView.aspx?PID=2025-17-1-9
REFERENCES:
1. Castro R, Casanas B. Orthopoxviruses and human disease. In Global Virology II-HIV and NeuroAIDS 2017 (pp. 689-697). Springer, New York, NY.
2. Walsh M. Smallpox: the disease and strategies for its control. Nursing times. 2002; Dec 1; 98(51): 26-7.
3. Diaz-Cánova D, Mavian C, Brinkmann A, Nitsche A, Moens U, Okeke MI. Genomic sequencing and phylogenomics of cowpox virus. Viruses. 2022; Sep 28; 14(10): 2134.
4. Ferdous J, Barek MA, Hossen MS, Bhowmik KK, Islam MS. A review on monkeypox virus outbreak: New challenge for world. Health science reports. 2023; Jan;6(1): e1007.
5. Sharma A, Prasad H, Kaeley N, Bondalapati A, Edara L, Kumar YA. Monkeypox epidemiology, clinical presentation, and transmission: a systematic review. International Journal of Emergency Medicine. 2023; Mar 17; 16(1): 20.
6. Tiecco G, Degli Antoni M, Storti S, Tomasoni LR, Castelli F, Quiros-Roldan E. Monkeypox, a literature review: what is new and where does this concerning virus come from?. Viruses. 2022 Aug 27;14(9):1894.
7. Nyame J, Punniyakotti S, Khera K, Pal RS, Varadarajan N, Sharma P. Challenges in the treatment and prevention of Monkeypox infection; a comprehensive review. Acta Tropica. 2023; Sep 1; 245: 106960.
8. Harapan H, Ophinni Y, Megawati D, Frediansyah A, Mamada SS, Salampe M, Bin Emran T, Winardi W, Fathima R, Sirinam S, Sittikul P. Monkeypox: a comprehensive review. Viruses. 2022; Sep 29; 14(10): 2155.
9. Di Gennaro F, Veronese N, Marotta C, Shin JI, Koyanagi A, Silenzi A, Antunes M, Saracino A, Bavaro DF, Soysal P, Segala FV. Human monkeypox: a comprehensive narrative review and analysis of the public health implications. Microorganisms. 2022; Aug 12;10(8): 1633.
10. McLean J, Stoeckle K, Huang S, Berardi J, Gray B, Glesby MJ, Zucker J. Tecovirimat treatment of people with HIV during the 2022 mpox outbreak: a retrospective cohort study. Annals of internal medicine. 2023; May;176(5): 642-8.
11. Magee WC, Hostetler KY, Evans DH. Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate. Antimicrobial Agents and Chemotherapy. 2005; Aug; 49(8): 3153-62.
12. Mercer J. Vaccinia Virus. Springer New York; 2019.
13. El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Research. 2016 Oct 1; 134:58-62.
14. Detweiler CJ, Mueller SB, Sung AD, Saullo JL, Prasad VK, Cardona DM. Brincidofovir (CMX001) toxicity associated with epithelial apoptosis and crypt drop out in a hematopoietic cell transplant patient: challenges in distinguishing drug toxicity from GVHD. Journal of Pediatric Hematology/Oncology. 2018; Aug 1; 40(6): e364-8.